These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 27879023)

  • 1. Potential effect of ezetimibe against Mycobacterium tuberculosis infection in type II diabetes.
    Tsai IF; Kuo CP; Lin AB; Chien MN; Ho HT; Wei TY; Wu CL; Lu YT
    Respirology; 2017 Apr; 22(3):559-566. PubMed ID: 27879023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidized low-density lipoprotein (oxLDL) supports Mycobacterium tuberculosis survival in macrophages by inducing lysosomal dysfunction.
    Vrieling F; Wilson L; Rensen PCN; Walzl G; Ottenhoff THM; Joosten SA
    PLoS Pathog; 2019 Apr; 15(4):e1007724. PubMed ID: 30998773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol plays a larger role during Mycobacterium tuberculosis in vitro dormancy and reactivation than previously suspected.
    Soto-Ramirez MD; Aguilar-Ayala DA; Garcia-Morales L; Rodriguez-Peredo SM; Badillo-Lopez C; Rios-Muñiz DE; Meza-Segura MA; Rivera-Morales GY; Leon-Solis L; Cerna-Cortes JF; Rivera-Gutierrez S; Helguera-Repetto AC; Gonzalez-Y-Merchand JA
    Tuberculosis (Edinb); 2017 Mar; 103():1-9. PubMed ID: 28237027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small Molecule Mediated Restoration of Mitochondrial Function Augments Anti-Mycobacterial Activity of Human Macrophages Subjected to Cholesterol Induced Asymptomatic Dyslipidemia.
    Asalla S; Mohareer K; Banerjee S
    Front Cell Infect Microbiol; 2017; 7():439. PubMed ID: 29067283
    [No Abstract]   [Full Text] [Related]  

  • 5. WNT6/ACC2-induced storage of triacylglycerols in macrophages is exploited by Mycobacterium tuberculosis.
    Brandenburg J; Marwitz S; Tazoll SC; Waldow F; Kalsdorf B; Vierbuchen T; Scholzen T; Gross A; Goldenbaum S; Hölscher A; Hein M; Linnemann L; Reimann M; Kispert A; Leitges M; Rupp J; Lange C; Niemann S; Behrends J; Goldmann T; Heine H; Schaible UE; Hölscher C; Schwudke D; Reiling N
    J Clin Invest; 2021 Aug; 131(16):. PubMed ID: 34255743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dormant ovoid cells of Mycobacterium tuberculosis are formed in response to gradual external acidification.
    Shleeva MO; Kudykina YK; Vostroknutova GN; Suzina NE; Mulyukin AL; Kaprelyants AS
    Tuberculosis (Edinb); 2011 Mar; 91(2):146-54. PubMed ID: 21262587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel inhibitors of cholesterol degradation in Mycobacterium tuberculosis reveal how the bacterium's metabolism is constrained by the intracellular environment.
    VanderVen BC; Fahey RJ; Lee W; Liu Y; Abramovitch RB; Memmott C; Crowe AM; Eltis LD; Perola E; Deininger DD; Wang T; Locher CP; Russell DG
    PLoS Pathog; 2015 Feb; 11(2):e1004679. PubMed ID: 25675247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dormant Mycobacterium tuberculosis fails to block phagosome maturation and shows unexpected capacity to stimulate specific human T lymphocytes.
    Mariotti S; Pardini M; Gagliardi MC; Teloni R; Giannoni F; Fraziano M; Lozupone F; Meschini S; Nisini R
    J Immunol; 2013 Jul; 191(1):274-82. PubMed ID: 23733870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human granuloma in vitro model, for TB dormancy and resuscitation.
    Kapoor N; Pawar S; Sirakova TD; Deb C; Warren WL; Kolattukudy PE
    PLoS One; 2013; 8(1):e53657. PubMed ID: 23308269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breaking fat! How mycobacteria and other intracellular pathogens manipulate host lipid droplets.
    Barisch C; Soldati T
    Biochimie; 2017 Oct; 141():54-61. PubMed ID: 28587792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling of Mycobacterium tuberculosis dormancy in bacterial cultures.
    Batyrshina YR; Schwartz YS
    Tuberculosis (Edinb); 2019 Jul; 117():7-17. PubMed ID: 31378272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug targets in dormant Mycobacterium tuberculosis: can the conquest against tuberculosis become a reality?
    Gupta VK; Kumar MM; Singh D; Bisht D; Sharma S
    Infect Dis (Lond); 2018 Feb; 50(2):81-94. PubMed ID: 28933243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioenergetic Heterogeneity in Mycobacterium tuberculosis Residing in Different Subcellular Niches.
    Akela AK; Kumar A
    mBio; 2021 Jun; 12(3):e0108821. PubMed ID: 34060333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel in vitro multiple-stress dormancy model for Mycobacterium tuberculosis generates a lipid-loaded, drug-tolerant, dormant pathogen.
    Deb C; Lee CM; Dubey VS; Daniel J; Abomoelak B; Sirakova TD; Pawar S; Rogers L; Kolattukudy PE
    PLoS One; 2009 Jun; 4(6):e6077. PubMed ID: 19562030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptomic Characterization of Tuberculous Sputum Reveals a Host Warburg Effect and Microbial Cholesterol Catabolism.
    Lai RPJ; Cortes T; Marais S; Rockwood N; Burke ML; Garza-Garcia A; Horswell S; Sesay AK; O'Garra A; Young DB; Wilkinson RJ
    mBio; 2021 Dec; 12(6):e0176621. PubMed ID: 34872348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycobacterium tuberculosis uses host triacylglycerol to accumulate lipid droplets and acquires a dormancy-like phenotype in lipid-loaded macrophages.
    Daniel J; Maamar H; Deb C; Sirakova TD; Kolattukudy PE
    PLoS Pathog; 2011 Jun; 7(6):e1002093. PubMed ID: 21731490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type-2 diabetes alters the basal phenotype of human macrophages and diminishes their capacity to respond, internalise, and control Mycobacterium tuberculosis.
    Lopez-Lopez N; Martinez AGR; Garcia-Hernandez MH; Hernandez-Pando R; Castañeda-Delgado JE; Lugo-Villarino G; Cougoule C; Neyrolles O; Rivas-Santiago B; Valtierra-Alvarado MA; Rubio-Caceres M; Enciso-Moreno JA; Serrano CJ
    Mem Inst Oswaldo Cruz; 2018 Feb; 113(4):e170326. PubMed ID: 29513874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.